It also decreases the risk of cardiovascular events and helps with weight loss
Semaglutide-Induced lupus erythematosus with multiorgan involvement
Figure 2 Within the SOC level, gastrointestinal system disorders in overall GLP-1 RAs were overreported compared with the background frequency (ROR 1.46, PRR 1.33, IC 0.41, EBGM 1.33), which were further attributed to liraglutide (ROR 2.39, PRR 1.84, IC 0.88, EBGM 1.33), dulaglutide (ROR 1.39, PRR 1.28, IC 0.36, EBGM 1.25), and semaglutide (ROR 3.00, PRR 2.10, IC 1.07, EBGM 2.10), while exenatide (ROR 0.57, PRR 0.63, IC 0.68, EBGM 0.63) and lixisenatide (ROR 0.51, PRR 0.57, IC 0.81, EBGM 0.57) did not show the association with gastrointestinal AEs ( Table 2 )
Keep a food and activity diary for a week or two to identify any patterns
The results, published in the Cochrane Database of Systematic Reviews , found all three jabs enabled users to lose a significant amount of weight compared to placebo alternatives
Serum IGF-1 levels, growth velocity and head circumference should be monitored during treatment and kept in the normal range